证券之星消息，近日明德生物(002932)新注册了《EasyPoint POCT智慧管理系统V1.0.0》项目的软件著作权。今年以来明德生物新注册软件著作权1个。结合公司2025年中报财务数据，2025上半年公司在研发方面投入了4681.89万元，同比减15.22%。通过天眼查大数据分析，武汉明德生物科技股份有限公司共对外投资了24家企业，参与招投标项目706次；财产线索方面有商标信息183条，专利信息218条，著作权信息101条；此外企业还拥有行政许可699个。数据来源：天眼查APP为证券之星据公开信息整理，由AI算法生成(网信算备310104345710301240019号)，不构成投资建议。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.